Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2013
November 2013, Vol 4, No 9
November 2013, Vol 4, No 9
Hispanics More Likely than Caucasians to Develop Major Complications after Radical Cystectomy
By
Rosemary Frei, MSc
Bladder Cancer
November 2013, Vol 4, No 9
Vancouver, Canada—The odds of having a major complication after a radical cystectomy, which is performed as part of the treatment for bladder cancer, are higher for Hispanics than for Caucasians, researchers have found. They calculated that the rate of such complications was 23.53% for Hispanic Americans compared with 16.09% for Caucasian Americans.
Read Article
The Cost of End-of-Life Care in Oncology
By
Craig Deligdish, MD
End-of-Life Care
,
From the Editor
,
Policies & Guidelines
,
Value Peer-spectives
November 2013, Vol 4, No 9
The recent Institute of Medicine report “Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis” addressed the important issues of delivering high-quality cancer care, including end-of-life care.
Read Article
Sulfasalazine Fails to Prevent Radiotherapy-Induced Diarrhea
By
Charles Bankhead
Radiotherapy in Focus
,
Personalized Medicine
November 2013, Vol 4, No 9
Atlanta, GA—Patients with cancer treated with pelvic radiation did not have fewer bouts of diarrhea when treated prophylactically with the anti-inflammatory drug sulfasalazine (Azulfidine), a randomized trial showed. Patients receiving sulfasalazine had radiation-associated severe diarrhea almost 3 times as often as patients receiving placebo.
Read Article
Expanded Radiotherapy Improves Breast Cancer Control
By
Charles Bankhead
Radiotherapy in Focus
,
Personalized Medicine
November 2013, Vol 4, No 9
Amsterdam, The Netherlands—Expanded radiotherapy led to significantly better disease-free survival (DFS) and metastasis-free survival (MFS) rates in women with early breast cancer, according to the results of a large study reported at the European Cancer Congress 2013.
Read Article
Ten Steps to Achieving Value-Based Care at the Mayo Clinic
By
Rosemary Frei, MSc
Value in Oncology
,
Value-Based Care
November 2013, Vol 4, No 9
Phoenix, AZ—The staff at the Mayo Clinic are working to “bend the cost curve” and optimize resource utilization efficiency while continuing to provide high-quality care to their large population of patients, said Kari Bunkers, MD, Chief Medical Information Officer, Mayo Clinic Health System, and Medical Director, Mayo Clinic Office of Population Health Management (OPHM) at the American Medical Group Association 2013 Institute for Quality Leadership conference.
Read Article
Physician-Focused Improvement in Patient Satisfaction at the Cleveland Clinic
By
Rosemary Frei, MSc
Patient Communication
,
Value Peer-spectives
November 2013, Vol 4, No 9
>Phoenix, AZ—The degree of patient satisfaction with healthcare is becoming paramount in the new era of value-based care, according to James Merlino, MD, Chief Experience Officer, and Associate Chief of Staff, Patient Experience Office, Cleveland Clinic Health System (CCHS), OH, who discussed high-value healthcare at the American Medical Group Association 2013 Institute for Quality Leadership conference.
Read Article
Oral VEGF Inhibitor, Cediranib, Improves Survival in Recurrent Ovarian Cancer
By
Charles Bankhead
Ovarian Cancer
November 2013, Vol 4, No 9
Treatment with the oral angiogenesis inhibitor cediranib led to significant improvements in overall survival (OS) and progression-free survival (PFS) in patients with recurrent ovarian cancer, according to new data reported at the European Cancer Congress 2013.
Read Article
Gilotrif: Second-Generation Tyrosine Kinase Inhibitor Indicated for the First-Line Treatment of Patients with Non–Small-Cell Lung Cancer and EGFR Mutation
By
Lisa A. Raedler, PhD, RPh
Drug Updates
November 2013, Vol 4, No 9
Read Article
Next-Generation Sequencing Identifies “Actionable” Genomic Alterations in Solid Tumors
By
Wayne Kuznar
Personalized Medicine
November 2013, Vol 4, No 9
Boston, MA—Next-generation sequencing is a valuable tool to identify actionable genomic alterations that may be present in a tumor sample, said Gary A. Palmer, MD, JD, MBA, MPH, Senior Vice President of Medical Affairs and Commercial Development, Foundation Medicine, Cambridge, MA, at the Second Global Biomarkers Consortium annual conference.
Read Article
Practical Problems Must Be Overcome to Move Personalized Medicine Forward in Oncology
By
Wayne Kuznar
Personalized Medicine
November 2013, Vol 4, No 9
Boston, MA—Incorporating personalized medicine into everyday oncology clinical practice will require new paradigms in an effort to match patients with cancer with the appropriate therapies, as well as attempts to treat solid tumors at an earlier stage with targeted agents, said Razelle Kurzrock, MD, Director, Center for Personalized Cancer Therapy, University of California, San Diego (UCSD) Moores Cancer Center, at the Second Global Biomarkers Consortium annual conference.
Read Article
Page 1 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma